FN Archimer Export Format
PT J
TI Managing marine mollusc diseases in the context of regional and international commerce: policy issues and emerging concerns
BT 
AF CARNEGIE, Ryan B.
   ARZUL, Isabelle
   BUSHEK, David
AS 1:1;2:2;3:3;
FF 1:;2:PDG-RBE-SG2M-LGPMM;3:;
C1 Virginia Inst Marine Sci, Coll William & Mary, Dept Aquat Hlth Sci, POB 1346, Gloucester Point, VA 23062 USA.
   IFREMER, LGPMM SG2M, Lab Genet & Pathol Mollusques Marins, Ave Mus Loup, F-17390 La Tremblade, France.
   Rutgers State Univ, Haskin Shellfish Res Lab, 6959 Miller Ave, Port Norris, NJ 08349 USA.
C2 VIRGINIA INST MARINE SCI, USA
   IFREMER, FRANCE
   UNIV RUTGERS STATE, USA
SI LA TREMBLADE
SE PDG-RBE-SG2M-LGPMM
IN WOS Ifremer jusqu'en 2018
   copubli-int-hors-europe
IF 5.846
TC 56
UR https://archimer.ifremer.fr/doc/00313/42464/41837.pdf
LA English
DT Article
DE ;emerging disease;aquaculture health;OIE
AB Marine mollusc production contributes to food and economic security worldwide and provides valuable ecological services, yet diseases threaten these industries and wild populations. Although the infrastructure for mollusc aquaculture health management is well characterized, its foundations are not without flaws. Use of notifiable pathogen lists can leave blind spots with regard to detection of unlisted and emerging pathogens. Increased reliance on molecular tools has come without similar attention to diagnostic validation, raising questions about assay performance, and has been accompanied by a reduced emphasis on microscopic diagnostic expertise that could weaken pathogen detection capabilities. Persistent questions concerning pathogen biology and ecology promote regulatory paralysis that impedes trade and which could weaken biosecurity by driving commerce to surreptitious channels. Solutions that might be pursued to improve shellfish aquaculture health management include the establishment of more broad-based surveillance programmes, wider training and use of general methods like histopathology to ensure alertness to emerging diseases, an increased focus on assay assessment and validation as fundamental to assay development, investment in basic research, and application of risk analyses to improve regulation. A continual sharpening of diagnostic tools and approaches and deepening of scientific knowledge is necessary to manage diseases and promote sustainable molluscan shellfish industries.
PY 2016
PD MAR
SO Philosophical Transactions Of The Royal Society B-biological Sciences
SN 0962-8436
PU Royal Soc
VL 371
IS 1689
UT 000371148300013
DI 10.1098/rstb.2015.0215
ID 42464
ER

EF